FDA Approval Of Its Obesity Drug Has This Small Biotech Rocketing Upby SarahNovember 29, 2020April 17, 2021 With the first FDA-approved drug for weight management in people with rare genetic disorders of obesity – its first new drug approval – shares of this small biotech are surging. CLICK HERE. Tags:Biotech InvestingBiotech StocksFDA-Approved DrugInvestmentsInvestorSmall BiotechsSurging Biotechs